| Product Code: ETC12803509 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Latvia saw a consistent growth in HIV injection import shipments with a healthy Compound Annual Growth Rate (CAGR) of 8.6% from 2020 to 2024. The top exporting countries to Latvia for these injections were Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the strong growth, market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low in 2024. The growth rate from 2023 to 2024 was also impressive at 7.03%, indicating a positive trend in the market for HIV injections in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia HIV Injection Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia HIV Injection Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia HIV Injection Market - Industry Life Cycle |
3.4 Latvia HIV Injection Market - Porter's Five Forces |
3.5 Latvia HIV Injection Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Latvia HIV Injection Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
3.7 Latvia HIV Injection Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Latvia HIV Injection Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia HIV Injection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia HIV Injection Market Trends |
6 Latvia HIV Injection Market, By Types |
6.1 Latvia HIV Injection Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia HIV Injection Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Latvia HIV Injection Market Revenues & Volume, By Antiretroviral Injections, 2021 - 2031F |
6.1.4 Latvia HIV Injection Market Revenues & Volume, By Pre-Exposure Prophylaxis (PrEP) Injections, 2021 - 2031F |
6.1.5 Latvia HIV Injection Market Revenues & Volume, By Long-Acting Injectable Therapy, 2021 - 2031F |
6.1.6 Latvia HIV Injection Market Revenues & Volume, By Post-Exposure Prophylaxis (PEP) Injections, 2021 - 2031F |
6.2 Latvia HIV Injection Market, By Administration Route |
6.2.1 Overview and Analysis |
6.2.2 Latvia HIV Injection Market Revenues & Volume, By Intramuscular (IM) Injections, 2021 - 2031F |
6.2.3 Latvia HIV Injection Market Revenues & Volume, By Subcutaneous (SC) Injections, 2021 - 2031F |
6.3 Latvia HIV Injection Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Latvia HIV Injection Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Latvia HIV Injection Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Latvia HIV Injection Market Revenues & Volume, By Home Care, 2021 - 2031F |
6.4 Latvia HIV Injection Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia HIV Injection Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Latvia HIV Injection Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Latvia HIV Injection Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Latvia HIV Injection Market Import-Export Trade Statistics |
7.1 Latvia HIV Injection Market Export to Major Countries |
7.2 Latvia HIV Injection Market Imports from Major Countries |
8 Latvia HIV Injection Market Key Performance Indicators |
9 Latvia HIV Injection Market - Opportunity Assessment |
9.1 Latvia HIV Injection Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Latvia HIV Injection Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
9.3 Latvia HIV Injection Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Latvia HIV Injection Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia HIV Injection Market - Competitive Landscape |
10.1 Latvia HIV Injection Market Revenue Share, By Companies, 2024 |
10.2 Latvia HIV Injection Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here